Tablet

DigiCert and Macnica Bring Matter-Enabled Smart Home Solutions to Panasonic Room Air Products

Retrieved on: 
Tuesday, April 2, 2024
CSA, Connectivity Standards Alliance, Apple, Communication, Public-key cryptography, Digital, Name, Internet of things, Tablet, Knowledge, Internet, DigiCert, Policy, News, PKI, Cassette tape

Selected by CSA as the world's first Matter Root CA, DigiCert supports the project with high security and support capabilities backed by professional experience and knowledge based on the company’s certificate business experience and wide adoption worldwide. Macnica, with its expertise in the IoT and IT domains, played an important role in the implementation of the Matter-compliant digital certificates at Panasonic Group’s production plant--from deal discovery and management through implementation and post-deployment technical support. 

Key Points: 
  • Together, they will introduce the first room air conditioner in India equipped with Matter 1.21, a common standard for smart homes.
  • The certificates allow Panasonic room air conditioners to be seamlessly integrated into the Matter ecosystem, enabling users to control and monitor their room air conditioners from Matter-enabled devices such as smart speakers, smartphones, and tablets.
  • The Panasonic room air conditioner series equipped with the Matter Protocol is available at all major retailers and e-commerce platforms in India.
  • “The security of Panasonic room air conditioners has been greatly enhanced by adopting the latest solutions from DigiCert, a leading provider of digital certificates, in addition to the security-oriented Matter standard.

Junshi Biosciences Announces 2023 Full Year Financial Results and Provides Corporate Updates

Retrieved on: 
Friday, March 29, 2024
CPS, Patient, Lung cancer, IND, Infection, Cancer, Investment, Cisplatin, Paclitaxel, Melanoma, Marketing, RNA, New chemical entity, Gentlemen's agreement, NRDL, Food, Therapeutic Goods Administration, Biologics license application, Insurance, Research, Junshi, National Medical Products Administration, TGA, FDA, NMPA, Tablet, COVID-19, NPC, Spacecraft, DSM-IV codes, Dacarbazine, Axitinib, Total, Pharmaceutical industry

SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates.

Key Points: 
  • SHANGHAI, China, March 29, 2024 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences,” HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial results for the full year of 2023 and provided corporate updates.
  • Total research and development (“R&D”) expenses were approximately RMB1,937 million in 2023, representing a decrease of approximately 19% compared to 2022.
  • Loss attributable to owners was RMB2,282 million in 2023, representing a decrease of RMB104 million compared to the previous year.
  • This application was later approved for marketing in December 2023, marking the first and only approved perioperative therapy for lung cancer domestically.

China Medical System （867.HK）2023 Annual Results: Despite of the Temporary Financial Performance Pressure Fresh Catalysts Emerged from Successive Innovation Breakthroughs

Retrieved on: 
Thursday, March 28, 2024
Sclerotherapy, RMB, Conditional sentence, NDA, IND, Creativity, Small RNA, Marketing, Gastroenterology, Central nervous system, FIC, City, BIC, CMS, NRDL, Injection, Dermatology, CDMO, Commercialization, Tablet, Pharmacy, Methotrexate, Hospital, Acquisition, Gonadotropin-releasing hormone, RCT, VBP, Rheumatoid arthritis, Growth, Varicose veins, Ecosystem, Blue, Government, Ophthalmology

SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results.

Key Points: 
  • SHENZHEN, CHINA, March 27, 2024 (GLOBE NEWSWIRE) -- On March 27, 2024, China Medical System (“CMS” or the “Company”) released its 2023 annual results.
  • Based on above, CMS has successfully entered into its “New Period” of innovation and internationalization development.
  • 4 innovative drugs have started large-scale clinical application, unveiling CMS’s first year of commercialization era of innovative drugs.
  • Under its compliant and efficient commercialization system, the Company's innovative products and exclusive drugs will grow steadily.

MediciNova Receives a Notice of Allowance for a New Patent Covering MN-166 (ibudilast) for the Treatment of Macular Injury in Japan

Retrieved on: 
Tuesday, March 26, 2024
OCT, Optical coherence tomography, Patent, Multiple sclerosis, Capsule, Tablet, Code, MD, SPRINT, MPH, Tokyo Stock Exchange, Pharmaceutical industry

Once issued, this patent is expected to expire no earlier than October 2039.

Key Points: 
  • Once issued, this patent is expected to expire no earlier than October 2039.
  • The allowed claims cover the use of MN-166 (ibudilast) for treating macular injury associated with progressive multiple sclerosis and for decreasing macular volume loss associated with progressive multiple sclerosis.
  • The allowed claims specifically cover both primary progressive multiple sclerosis and secondary progressive multiple sclerosis.
  • Previously, we reported positive Optical Coherence Tomography (OCT) results from the SPRINT-MS Phase 2b trial of MN-166 in progressive multiple sclerosis.

Powerful New Web Management Console for SIOS LifeKeeper for Linux Dramatically Simplifies Application High Availability

Retrieved on: 
Tuesday, March 26, 2024
ARK, Automation, Organization, Disaster, Red Hat Enterprise Linux, Environment, Web design, Reputational damage, Risk, Complex, SAN, Tablet, Java, SAP, Linux, Global marketing, SIOS, Progress, SIOS LifeKeeper, Database, ERPs, RHEL, Risk management

The introduction of the SIOS LifeKeeper Web Management Console marks a pivotal moment in the pursuit of simpler, more comprehensive application HA/DR.

Key Points: 
  • The introduction of the SIOS LifeKeeper Web Management Console marks a pivotal moment in the pursuit of simpler, more comprehensive application HA/DR.
  • Masahiro Arai, Chief Operating Officer, SIOS Technology, emphasized the transformative potential of the latest LifeKeeper release, "The new SIOS LifeKeeper Web Management Console is the first step in realizing our vision of empowering IT administrators with simple, holistic application HA/DR.
  • By empowering IT administrators with intuitive tools and cutting-edge technology, the SIOS LifeKeeper Web Management Console represents a significant step forward in safeguarding critical enterprise systems against downtime and disasters.
  • SIOS is committed to offering support for a wide array of applications, platforms and environments, ensuring application availability across various systems.

Introducing the New Gabriels Technology Solutions' Website: Redefining Online Presence for Real Estate Software Providers

Retrieved on: 
Tuesday, April 9, 2024
Customer, Multimedia, Tablet, Social media, Web design, Blog, Online shopping

The redesigned website offers visitors a seamless and informative journey, showcasing our latest real estate agent and real estate broker products, services, industry insights, and company news.

Key Points: 
  • The redesigned website offers visitors a seamless and informative journey, showcasing our latest real estate agent and real estate broker products, services, industry insights, and company news.
  • Key features of the new Gabriels Technology Solutions website include:
    Sleek Design: A visually appealing design that reflects our brand identity and values, ensuring a memorable user experience.
  • The launch of the new website and blog underscores Gabriels Technology Solutions' ongoing commitment to innovation, customer-centricity, and continuous improvement.
  • For more information about Gabriels Technology Solutions and its range of products/services, please visit https://www.gabrielstechnology.com .

Family Health & Wellness Brand, Mommy's Bliss, Launches Lactation Hydration Drink Tablets

Retrieved on: 
Tuesday, April 9, 2024
Mother, Vitamin, Tablet, Mommy's Bliss, Amazon, Disease, Milk, Electrolyte, Athlete, Skin, Water, Biotin, Mommy, Parent, Nail, Food

RICHMOND, Calif., April 9, 2024 /PRNewswire-PRWeb/ -- Mommy's Bliss, a premier wellness company that has been a leader in bringing innovative, high-quality products to families across the country, today announced the addition of Mommy's Bliss Lactation Hydration Drink Tablets to their Lactation Support Collection of products for moms.

Key Points: 
  • RICHMOND, Calif., April 9, 2024 /PRNewswire-PRWeb/ -- Mommy's Bliss , a premier wellness company that has been a leader in bringing innovative, high-quality products to families across the country, today announced the addition of Mommy's Bliss Lactation Hydration Drink Tablets to their Lactation Support Collection of products for moms.
  • I'm excited to launch a product that truly supports hydration for moms in a way specially crafted for this lactation journey.
  • Mommy's Bliss Lactation Hydration Drink Tablets are now available for $7.99 on the Mommy's Bliss website as well as through Amazon and Target .
  • For more information about the Lactation Hydration Drink Tablets and other Mommy's Bliss products, visit http://www.mommysbliss.com .

Snow-Capped Adventure: Project Catamount Brings Skiing Excitement to Upstate Washington!

Retrieved on: 
Tuesday, April 9, 2024
GM, CarPlay, Silver, Range Rover Classic, Tablet, Cougar, Defender, Land Rover, Adventure, USB, HERE, Safety, Summit, ECD, HP, Bluetooth, Automotive industry

Project Catamount takes on its newest adventure as it plows through the snowy ski slopes in Snoqualmie Pass, Washington.

Key Points: 
  • Project Catamount takes on its newest adventure as it plows through the snowy ski slopes in Snoqualmie Pass, Washington.
  • Like many ECD vehicles, Project Catamount was built to take on diverse driving conditions, while doing it in style.
  • Powered by a robust Chevrolet LT1 V8 engine and coupled with an 8-Speed automatic transmission, it can take on diverse terrains with ease.
  • Although Project Catamount is a classic, it is also packed with all the modern amenities to enhance the driving experience.

SONIFI Health expands support for hospital virtual care with telehealth partnerships and system optimizations

Retrieved on: 
Tuesday, April 9, 2024
Hospital, Customer success, Health, Patient, Tablet, Education, Nursing, CTI, Workflow, Investment, Safety, EHR, Vidyo

SONIFI Health's virtual care-integrated platform upgrades how smart hospital rooms can benefit clinicians and patients.

Key Points: 
  • SONIFI Health's virtual care-integrated platform upgrades how smart hospital rooms can benefit clinicians and patients.
  • SONIFI Health integrates with a broad range of telehealth solutions—including those from Amwell, care.ai, CareView, CTI, Vidyo, Vitalchat and more—to incorporate virtual care onto its interactive TV system.
  • SONIFI Health has been collaborating with their customers and telehealth vendors to enable multiple virtual care use cases that help clinicians work more efficiently and effectively, including remote patient consults and virtual nursing.
  • SONIFI Health is proud to support and enable this next step for smart hospital rooms, where technology is improving care while benefiting both clinicians and patients."

BrainCheck Showcases Latest Innovations at American Medical Group Association Annual Conference

Retrieved on: 
Tuesday, April 9, 2024
Diagnosis, AMGA, Conference, Screen, Deficit spending, Risk, Patient, Tablet, American Medical Group Association, MD, D.O, Summit Health, Amnesia, Cognition, Pathology, Dementia, FDA, Medical device

AUSTIN, Texas, April 9, 2024 /PRNewswire/ -- BrainCheck, Inc., a digital health innovator delivering next-generation technology into the growing digital cognitive assessment market, will showcase its comprehensive cognitive assessment platform, including its latest innovation, Screen™, in booth #202 at the American Medical Group Association (AMGA) Annual Conference from April 9-12 in Orlando, FL. Chelsea Dugan, Vice President of Marketing, and members of the BrainCheck team will attend the event to share BrainCheck's latest technology with medical groups and health system executives nationwide.

Key Points: 
  • Chelsea Dugan, Vice President of Marketing, and members of the BrainCheck team will attend the event to share BrainCheck's latest technology with medical groups and health system executives nationwide.
  • Expertly designed with patients in mind, BrainCheck's clinically proven platform offers a comprehensive digital solution, streamlining screening, assessment, care planning, and monitoring.
  • "BrainCheck's technology has transformed the way we assess patients' cognitive health in our practice," said Eric R. Penniman, D.O., Executive Medical Director, Summit Medical Group.
  • Early detection of cognitive impairment is key to unlocking opportunities to preserve patients' brain health," said Reza Ghomi, MD, MSE, neuropsychiatrist and Chief Medical Officer at BrainCheck.